Gilead Sciences Inc

Healthcare · Drug Manufacturers - General

150.10$ -0.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Gilead Sciences Inc (GILD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 59,023 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GILD
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	311	352	488	437	678	795	1,288	1,555	2,156	3,766	4,086	5,835	6,937	9,699	11,593	17,303	21,240	22,579	34,664	51,839	56,977	70,283	63,675	61,627	68,407	67,952	63,171	62,125	58,995	59,023
Current Assets	300	340	417	372	594	708	1,184	1,266	1,850	3,092	2,429	3,028	4,278	4,813	5,708	13,919	6,156	6,997	17,747	34,017	38,481	31,823	35,836	30,296	15,996	14,772	14,443	16,085	19,173	18,342
Cash	132	32	101	47	197	123	617	195	281	708	816	968	1,459	1,273	908	9,884	1,804	2,113	10,027	12,851	8,229	7,588	17,940	11,631	5,997	5,338	5,412	6,085	9,991	7,564
Cash & Short-Term Investments	132	32	101	294	513	583	942	707	1,254	2,311	937	1,172	1,790	1,657	2,099	9,900	1,862	2,132	11,726	26,208	32,380	25,510	30,089	24,352	7,408	6,520	6,385	7,264	11,568	9,613
Receivables	–	–	43	46	49	74	175	235	371	396	609	795	1,023	1,390	1,622	1,951	1,751	2,182	4,635	5,854	4,514	3,851	3,327	3,582	4,892	4,493	4,777	4,660	4,420	4,913
Inventory	–	–	17	21	21	39	52	98	136	217	564	600	928	1,052	1,204	1,390	1,745	1,697	1,386	1,955	1,587	801	814	922	1,683	1,618	1,507	1,787	1,710	1,774
Property, Plant & Equipment	–	–	–	–	55	63	68	198	223	243	361	448	529	700	701	774	1,100	1,166	1,674	2,276	2,865	3,295	4,006	4,502	4,967	5,121	5,475	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	123	1,525	533	1,004	1,061	1,169	1,172	1,172	1,172	4,159	4,117	4,117	8,108	8,332	8,314	8,314	8,314	8,314
Intangible Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	1,525	893	1,063	11,736	11,900	11,073	10,247	8,971	17,100	15,738	13,786	33,126	33,455	28,893	26,454	19,948	16,978
Total Liabilities	19	35	154	140	327	342	717	552	285	739	2,217	2,234	2,471	3,193	5,471	10,436	11,696	10,834	18,845	32,726	37,614	49,782	42,141	38,977	50,186	46,888	41,962	39,376	39,749	36,405
Current Liabilities	16	33	57	48	58	80	105	186	253	465	764	736	1,221	1,872	2,465	2,515	4,238	6,407	5,618	9,891	9,219	11,635	10,605	9,759	11,397	11,610	11,238	11,280	12,004	11,813
Short-Term Debt	3.6	1.9	4.8	3.2	3.0	1.5	0.2	0.1	0.2	60	19	0.3	5.6	11	646	1.6	1,169	2,697	15	2.0	1,408	2,747	2,748	2,499	2,757	1,516	2,273	1,798	1,815	2,807
Accounts Payable	2.5	3.3	7.7	9.5	12	19	24	36	48	71	367	290	601	811	803	1,206	1,327	1,256	955	1,178	1,206	814	790	713	844	705	905	550	833	715
Long-Term Debt	–	–	–	–	252	250	595	345	0.2	241	1,381	1,301	1,300	1,155	2,839	7,606	7,055	3,939	11,921	21,195	26,346	30,795	24,574	22,094	28,645	25,179	22,957	23,189	24,896	22,129
Shareholders' Equity	292	317	334	297	351	452	571	1,003	1,871	3,028	1,816	3,460	4,273	6,367	5,864	6,739	9,303	11,370	15,819	19,113	19,363	20,442	21,387	22,525	18,202	21,069	21,240	22,833	19,330	22,702
Retained Earnings	-135	-163	-383	-449	-506	-454	-382	-454	-4.3	810	-891	249	300	1,995	1,184	1,777	3,705	6,106	12,732	18,001	18,154	19,012	19,024	19,388	14,381	16,324	15,687	16,304	11,497	13,730
Shares Outstanding	889	1,040	1,312	1,370	1,457	1,619	1,652	1,609	1,857	1,897	1,836	1,929	1,918	1,868	1,747	1,580	1,583	1,695	1,647	1,521	1,358	1,319	1,308	1,277	1,263	1,262	1,262	1,258	1,255	1,255

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings